134 related articles for article (PubMed ID: 2887614)
21. Comparison of 40 mg famotidine nightly and 150 mg ranitidine b.d.: ulcer healing and symptom relief in benign gastric ulcer.
Cochran KM; Cockel R; Crowe J; Dickinson RJ; Gent AE; Kennedy NP; Royston CM; Cedar E; Mann SG
Aliment Pharmacol Ther; 1989 Oct; 3(5):461-70. PubMed ID: 2518859
[TBL] [Abstract][Full Text] [Related]
22. A multicenter, randomized, double-blind study comparing famotidine with cimetidine in the treatment of active duodenal ulcer disease.
Rodrigo L; Viver J; Conchillo F; Barrio E; Forné M; Zozaya JM; Alvarez A; Dieguez P; Muñoz M; Panés J
Digestion; 1989; 42(2):86-92. PubMed ID: 2570005
[TBL] [Abstract][Full Text] [Related]
23. Determining the optimal dosage regimen for H2-receptor antagonist therapy--a dose validation approach.
Young MD; Frank WO; Dickson BD; Peace KP; Braverman A; Mounce W
Aliment Pharmacol Ther; 1989 Feb; 3(1):47-57. PubMed ID: 2577482
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of acute stomach ulcer with H2 receptor antagonists. A direct therapy comparison with 300 mg nizatidine nightly and 2 times 150 mg nizatidine with twice daily 150 mg ranitidine].
Arnold R; Beckenbach P; Bock H; Bormann R; Brunner G; Daake H; Dammann HG; Dietrich K; Fuerer M; Geiter B
Fortschr Med; 1989 Jun; 107(17):390-4. PubMed ID: 2568327
[TBL] [Abstract][Full Text] [Related]
25. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
26. A single night time dose of ranitidine in the acute treatment of gastric ulcer: a European multicentre trial.
Ryan FP; Jorde R; Ehsanullah RS; Summers K; Wood JR
Gut; 1986 Jul; 27(7):784-8. PubMed ID: 3525337
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of gastric ulcer with sucralfate and famotidine].
Hoffenberg P; Reyes V; Palma J; Ossa P; Maggiolo P; Klinger J
Rev Med Chil; 1991 Jan; 119(1):45-9. PubMed ID: 1824143
[TBL] [Abstract][Full Text] [Related]
28. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal therapy with famotidine for 1 year is effective in preventing relapse of gastric ulcer.
Berlin RG; Root JK; Cook TJ
Aliment Pharmacol Ther; 1991 Apr; 5(2):161-71. PubMed ID: 1888817
[TBL] [Abstract][Full Text] [Related]
30. [The effect of histamine H2 receptor blockers on reparative processes in the gastric mucosa of patients with gastric peptic ulcer].
Alekseenko SA; Timoshin SS
Ter Arkh; 1999; 71(2):23-6. PubMed ID: 10222548
[TBL] [Abstract][Full Text] [Related]
31. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
32. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
33. Famotidine versus cimetidine in the treatment of acute duodenal ulcer. Double-blind, randomized clinical trial comparing nocturnal administration of 40 mg famotidine to 800 mg cimetidine.
Hartmann H; Fölsch UR
Digestion; 1988; 39(3):156-61. PubMed ID: 3061859
[TBL] [Abstract][Full Text] [Related]
34. Healing and recurrence of active duodenal ulcer with nizatidine.
Cloud ML; Offen WW; Matsumoto C; Chernish SM
Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
[TBL] [Abstract][Full Text] [Related]
35. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
36. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
[TBL] [Abstract][Full Text] [Related]
37. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
38. A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
Alcalá-Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Digestion; 1989; 42(2):79-85. PubMed ID: 2670647
[TBL] [Abstract][Full Text] [Related]
39. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
[TBL] [Abstract][Full Text] [Related]
40. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs.
Taha AS; Hudson N; Hawkey CJ; Swannell AJ; Trye PN; Cottrell J; Mann SG; Simon TJ; Sturrock RD; Russell RI
N Engl J Med; 1996 May; 334(22):1435-9. PubMed ID: 8618582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
